Sepsis: Stimulation of energy-dependent protein breakdown resulting in protein loss in skeletal muscle

World Journal of Surgery

Volumn 22, Issue 2, 1998, Pages 203-208

  Hasseigren, Per Olof ^a   Fischer, Josef E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYTOKINE; ENZYME INHIBITOR; GLUCOCORTICOID; INTERLEUKIN 1; MUSCLE PROTEIN; MYOSIN; PROTEASOME; TUMOR NECROSIS FACTOR; UBIQUITIN;

ENERGY EXPENDITURE; ENERGY METABOLISM; HUMAN; MUSCLE ATROPHY; MUSCLE FATIGUE; MUSCLE METABOLISM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; REVIEW; SEPSIS; SKELETAL MUSCLE;

ENERGY METABOLISM; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; SEPSIS;

EID: 0031933789     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900370     Document Type: Review

References (51)

1. Clowes, G.H.A., George, B.C., Villee, C.A., Saravis, C.A.: Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N. Engl. J. Med. 308:545, 1983
2. Hasselgren, P.O., Talamini, M., James, J.H., Fischer, J.E.: Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Arch. Surg. 121:918, 1986
3. Hasselgren, P.O., James, J.H., Benson, D.W., Hall-Angerås, M., Angerås, U., Hiyama, D.T., Li, S., Fischer, J.E.: Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 38:634, 1989
4. Rosenblatt, S., Clowes, G.H.A., George, B.C., Hirsch, E., Lindberg, B.: Exchange of amino acids by muscle and liver in sepsis: comparative studies in vivo and in vitro. Arch. Surg. 118:167, 1983
5. Sax, H.C., Talamini, M.A., Hasselgren, P.O., Rosenblum, L., Ogle, C.K., Fischer, J.E.: Increased synthesis of secreted hepatic proteins during abdominal sepsis. J. Surg. Res. 44:109, 1988
6. Windmueller, H.G., Spaeth, A.E.: Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. J. Biol. Chem. 255:107, 1980
7. Newsholme, E.A., Parry-Billings, M.: Properties of glutamine release from muscle and its importance for the immune system. J. Parenter. Ent. Nutr. 14:63S, 1990
8. Downey, R.S., Monafo, W.W., Karl, I.E., Matthews, D.E., Bier, D.M.: Protein dynamics in skeletal muscle after trauma: local and systemic effects. Surgery 99:265, 1986
9. Fang, C.H., James, J.H., Ogle, C.K., Fischer, J.E., Hasselgren, P.O.: Influence of burn injury on protein metabolism in different types of skeletal muscle and the role of glucocorticoids. J. Am. Coll. Surg. 180:33, 1995
10. Lowell, B.B., Ruderman, N.B., Goodman, M.N.: Regulation of myofibrillar protein degradation in rat skeletal muscle during brief and prolonged starvation. Metabolism 35:1121, 1986
11. Kayati, A.C., Young, V.R., Goodman, M.N.: Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis. Am. J. Physiol. 252:E621, 1987
12. Young, V.R., Munro, H.N.: N-Methylhistidine (3-methylhistidine) and muscle protein turnover: an overview. Fed. Proc. 37:2291, 1978
13. Rennie, M.J., Millward, D.J.: 3-Methylhistidine excretion and urinary 3-methylhistidine/creatinine ratio are poor indicators of skeletal muscle protein breakdown. Clin. Sci. 65:217, 1983
14. Long, C.L., Birkhahn, R.H., Geiger, J.W., Betts, J.E., Schiller, W.R., Blakemore, W.S.: Urinary excretion of 3-methylhistidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma. Metabolism 30:765, 1981
15. Long, C.L., Birkhahn, R.H., Geiger, J.W., Blakemore, W.S.: Urinary excretion of 3-methylhistidine before and after major surgical operation. Metabolism 33:250, 1984
16. Fong, Y., Moldawer, L.L., Shires, T., Lowry, S.F.: The biological characteristics of cytokines and their implication in surgical injury. Surg. Gynecol. Obstet. 170:363, 1990
17. Zamir, O., Hasseigren, P.O., von Allmen D., Fischer, J.E.: The effect of interleukin-1α and the glucocorticoid receptor blocker RU38486 on total and myofibrillar protein breakdown in skeletal muscle. J. Surg. Res. 50:579, 1991
18. Zamir, O., Hasselgren, P.O., O'Brien, W., Thompson, R.C., Fischer, J.E.: Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). Ann. Surg. 216:381, 1992
19. Zamir, O., O'Brien, W., Thompson, R.C., Bloedow, D.C., Fischer, J.E., Hasselgren, P.O.: Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int. J. Biochem. 26:943, 1994
20. Zamir, O., Hasselgren, P.O., Kunkel, S.L., Frederick, J., Higashiguchi, T., Fischer, J.E.: Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch. Surg. 127: 170, 1992
21. Moldawer, L.L., Svanoinger, G., Gelin, J., Lundholm, K.: Interleukin-1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am. J. Physiol. 253:C766, 1987
22. 2 production in rat skeletal muscle in fever is signalled by a macrophage product distinct from interleukin-1 or other known monokines. J. Clin. Invest. 81:1378, 1988
23. Hasselgren, P.O., James, J.H., Benson, D.W., Li, S., Fischer, J.E.: Is there a circulating proteolysis-inducing factor during sepsis? Arch. Surg. 125:510, 1990
24. Goodman, M.N.: Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205:182, 1994
25. Ebisui, C., Tsujinaka, T., Morimoto, T., Kan, K., Iijima, S., Yano, M., Kominami, E., Tanaka, K., Monden, M.: Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin. Sci. 89:431, 1995
26. Tsujinaka, T., Ebisui, C., Fujita, J., Kishibuchi, M., Marimoto, T., Ogana, A., Katsume, A., Ohsugi, Y., Kominami, E., Monden, M.: Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem. Biophys. Res. Commun. 207:168, 1995
27. Garcia-Martinez, C., Lopez-Soriano, F.J., Argiles, J.M. Interleukin-6 does not activate protein breakdown in rat skeletal muscle. Cancer Lett. 76:1, 1994
28. Heinrich, P.C., Castell, J.V., Anders, T.: Interleukin-6 and the acute phase response. Biochem. J. 265:621, 1990
29. Wang, Q., Fischer, J.E., Hasselgren, P.O.: Treatment of endotoxemic mice with anti-IL-6 antibody paradoxically increases IL-6 levels and stimulates mucosal protein synthesis. Arch. Surg. 132:82, 1997
30. Mealy, K., van Lanschot, J.J.B., Robinson, B.G., Ramos, J., Wilmore, D.W.: Are the catabolic effects of tumor necrosis factor mediated by glucocorticoids? Arch. Surg. 125:42, 1990
31. Zamir, O., Hasselgren, P.O., Higashiguchi, T., Frederick, J., Fischer, J.E.: Tumor necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediat. Inflamm. 1:247, 1992
32. Darmann, D., Matthews, D.E., Bier, D.M.: Physiological hypercortisolemia increases proteolysis, glutamine and alanine production. Am. J. Physiol. 255:E366, 1988
33. Hall-Angerås, M., Angerås, U., Zamir, O., Hasselgren, P.O., Fischer, J.E.: Effect of the glucocorticoid receptor antagonist RU38486 on muscle protein breakdown in sepsis. Surgery 109:468, 1991
34. Tiao, G., Fagan, J., Roegner, V., Lieberman, M., Wang, J.J., Fischer, I.E., Hasselgren, P.O.: Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 97:339, 1996
35. Hall-Angerås, M., Angerås, U., Hasselgren, P.O., Fischer, J.E.: Corticosterone alone does not explain increased muscle proteolysis in septic rats. J. Surg. Res. 48:368, 1990
36. Goldberg, A.L.: The mechanism and functions of ATP-dependent proteases in bacterial and animal cells. Eur. J. Biochem. 203:9, 1992
37. Tiao, G., Fagan, J.M., Samuels, N., James, J.H., Hudson, K., Lieberman, M., Fischer, J.E., Hasselgren, P.O.: Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94:2255, 1994
38. Clowes, G.H.A., O'Donnell, T.F., Blackburn, G.L., Maki, T.N.: Energy metabolism and proteolysis in traumatized and septic man. Surg. Clin. North Am. 56:1169, 1976
39. Hershko, A., Ciechanover, A.: The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761, 1992
40. Hochstrasser, M.: Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:215, 1995
41. Hasselgren, P.O., Fischer, J.E.: The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions. Ann. Surg. 225: 307, 1997
42. Weissman, J.S., Sigler, P.B., Horwich, A.L.: From the cradle to the grave: ring complexes in the life of a protein. Science 268:523, 1995
43. Barinaga, M.: A new twist to the cell cycle. Science 269:631, 1995
44. Monaco, J.: A molecular model of MHC class-I-restricted antigen processing. Immunol. Today 13:173, 1992
45. Finco, T.S., Baldwin, A.S.: Mechanistic aspects of NFκB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263, 1995
46. Mitch, W.E., Medina, R., Grieber, S., May, R.C., England, B.K., Price, S.R., Bailey, J.L., Goldberg, A.L.: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93:2127, 1994
47. Fang, C.H., Tiao, G., James, J.H., Ogle, C., Fischer, J.E., Hasselgren, P.O.: Burn injury stimulates multiple proteolytic pathways in skeletal muscle including the ubiquitin-energy-dependent pathway. J. Am. Coll. Surg. 180:161, 1995
48. Llovera, M., Gaczia-Martinez, C., Agell, N., Marzabal, M., Lopez-Sariano, F.G., Argiles, J.M.: Ubiquitin gene expression is increased in skeletal muscle of tumor-bearing rats. FEBS Lett. 338:311, 1994
49. Tiao, G.M., Fagan, J., Lieberman, M., Fischer, J.E., Hasselgren, P.O.: Sepsis increases proteasome-dependent proteolysis and mRNA levels for the proteasome subunit RC3 in skeletal muscle. Surg. Forum 46:10, 1995
50. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Huang, D., Goldberg, A.L.: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761, 1994
51. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E.J., Schreiber, S.L.: Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726, 1995